1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsV Foundation & StacheStrong Glioblastoma Research Grant is sponsored by V Foundation for Cancer Research and StacheStrong. A partnership grant supporting research into glioblastoma treatment, focusing on advanced genetic and molecular approaches.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The V Foundation for Cancer Research and StacheStrong Announce $1 Million, Five-Year Grant Award to Advance Glioblastoma Research - V Foundation Skip to content The Latest ™ Surpasses $53 Million Raised All-Time"> Hockey Fights Cancer ™ Surpasses $53 Million Raised All-Time ® Mantra"> Stories of Survival: Living Jim Valvano’s “Don’t Give Up…Don’t Ever Give Up!
” ® Mantra Mania Club Celebrates a Decade of Community-Driven Impact Next Generation of Leaders Accelerate Victory Over Cancer® with $280,000 Raised at Victory Gala in NYC Leadership & Collaboration Diversity, Equity and Inclusion This long-term investment represents a significant step forward in advancing progress in glioblastoma treatments, where survival rates have remained largely unchanged for more than two decades.
Most patients diagnosed with glioblastoma survive just 12 to 18 months, emphasizing the urgent need for new scientific breakthroughs. Glioblastoma has proven to be difficult to treat due to its biological complexity. Tumors vary widely between patients – and even within different regions of the same tumor – making it extremely challenging to develop therapies that can effectively and durably target the disease.
Despite advances in cancer research broadly, progress in GBM has been incremental, and new approaches are urgently needed. “Our family saw firsthand how relentless this disease is and how few treatment options exist,” said Colin Gerner, CEO and Co-Founder of StacheStrong. “For too long, patients have faced the same prognosis without meaningful progress.
StacheStrong was founded on the belief that they deserve better. This $1 million, five-year commitment is a long-term investment in bold science that challenges the status quo. Through our partnership with the V Foundation and the exceptional team at Massachusetts General, we are accelerating research designed to uncover new vulnerabilities in glioblastoma and move closer to more effective, life-extending treatments.
” The newly funded research will support the laboratories of Mario Suvà, M. D. , Ph.
D. , and Liron Bar-Peled, Ph. D.
, both at Massachusetts General Hospital. Dr. Suvà’s team has spent the past decade pioneering advanced genetic and molecular approaches to study how glioblastoma evolves at the cellular level. Dr Bar-Peled has developed novel chemical approaches that dramatically expand the druggable space in cells.
By tracking how glioblastoma cells shift and adapt and pairing that insight with new tools that expand what researchers can target inside cancer cells, the team hopes to uncover hidden weaknesses that could lead to more precise and lasting treatments. StacheStrong was founded in 2018 in New York City after GJ Gerner was diagnosed at age 28 with glioblastoma.
What began as a personal effort to honor his strength has grown into a national nonprofit dedicated to funding faster, smarter brain cancer research. StacheStrong has raised millions of dollars to support innovative scientific work aimed at improving outcomes for patients with brain cancer.
Through this partnership, StacheStrong’s $1 million pledge will be deployed over five years through the V Foundation’s rigorous, peer-reviewed grant process, ensuring that funds are directed toward research with the highest scientific merit and potential patient impact. “Progress against glioblastoma will require new ideas and sustained commitment,” said Susanna Greer, Ph. D.
, Chief Scientific Officer of the V Foundation. “StacheStrong’s investment is powering innovative research that is pushing beyond incremental advances to better understand and target this aggressive disease. Partnerships like this ensure that the most promising science can move forward with urgency for the patients and families who need it most.
” Together, the V Foundation and StacheStrong aim to advance understanding and treatment of glioblastoma, supporting research that delivers measurable impact for patients and their families.
About the V Foundation for Cancer Research The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State University basketball coach, ESPN commentator and member of the Naismith Memorial Basketball Hall of Fame.
The V Foundation has funded over $458 million in game-changing cancer research grants in North America through a competitive process strictly supervised by a world-class Scientific Advisory Committee. Because the V Foundation has an endowment to cover administrative expenses, 100% of direct donations is awarded to cancer research and programs.
The V team is committed to funding the best scientists to accelerate Victory Over Cancer® and save lives. To learn more, visit v. org.
StacheStrong is a 501(c)3 nonprofit devoted to raising funds and awareness for brain cancer research. Defeating brain cancer and improving the quality of patients’ lives is our daily focus. Founded in 2018 following GJ Gerner’s diagnosis at age 28, StacheStrong has grown into a national organization committed to accelerating better outcomes for patients.
To date, StacheStrong has funded more than $7 million in research grants supporting over 65 studies at more than 40 leading institutions across the country. Through bold investments in science and a patient-centered mission, StacheStrong is working to drive breakthroughs, improve outcomes, and create better quality of life for those facing brain cancer. To learn more, visit StacheStrong.
org. the V Foundation for Cancer Research ™ Surpasses $53 Million Raised All-Time"> News Hockey Fights Cancer ™ Surpasses $53 Million Raised All-Time ™ Surpasses $53 Million Raised All-Time" class="btn btn-arrow">Find out more ® Mantra"> Video & Podcasts Stories of Survival: Living Jim Valvano’s “Don’t Give Up…Don’t Ever Give Up!
” ® Mantra ® Mantra" class="btn btn-arrow">Find out more Mania Club Celebrates a Decade of Community-Driven Impact Next Generation of Leaders Accelerate Victory Over Cancer® with $280,000 Raised at Victory Gala in NYC Statistics Statistics The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.
Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. Marketing Marketing The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage {vendor_count} vendors Accept Deny View preferences Save preferences View preferences Statistics Statistics The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.
Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. Marketing Marketing The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage {vendor_count} vendors Accept Deny View preferences Save preferences View preferences Manage consent Manage consent
According to the current listing, eligibility includes: Research institutions conducting glioblastoma research. Confirm the full requirements in the official notice before applying.
The current listing shows $1,000,000 over five years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
V Foundation & StacheStrong Glioblastoma Research Grant is funded by V Foundation for Cancer Research and StacheStrong. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article